To examine the role of CD163 in CRC development, patient survival as well as its relationships with other biomarkers in the present study, we examined CD163 expression in normal and cancer tissues from Swedish CRC patients and further analyzed the relationship between CD163 expression and patient outcomes, including survival. The gene discussed is CD163; the disease is colorectal carcinoma.